Malaysia

DUOPHARMA BIOTECH BHD DPHARMA

BURSA Healthcare MYR

Duopharma Biotech Berhad, formerly known as CCM Duopharma Biotech Berhad. Duopharma core competencies in the pharmaceutical industry include manufacturing, research and development, and commercialization and marketing of over 300 generic drugs, including Omesec and Prelica, as well as Consumer Healthcare (CHC) products such as CHAMPS, FLAVETTES, PROVITON, and Uphamol, which are well-known and accepted by consumers in Malaysia, the region, and around the world. With technological and commercialization agreements with trustworthy and powerful international partners, the Company has also ventured into the biosimilars space.Their headquarters is located in Kuala Lumpur, Malaysia.

Current Price MYR 1.31
Daily Change -1.5%
Market Cap MYR 1.26 B
Shares Outstanding 961.94 M
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart